Novo Nordisk (NYSE: NVO) closed at $50.96 in the latest trading session, posting a gain of 2.6% against the S&P 500’s modest daily rise of just 0.21%.
The Dow Jones Industrial Average climbed 1.03% on the same day, while the tech-heavy Nasdaq slipped 0.22%, making NVO’s performance one of the standout moves in the session.
Over the past month, Novo Nordisk shares have risen 2.75%, comfortably outpacing the Medical sector’s l…
Novo Nordisk (NYSE: NVO) Stock Outpaces The S&P 500 As Analysts Watch Upcoming Earnings Closely
July 29, 2026